Blog Posts

Visante Webinar: 340B Current Issues and Policy Update

SPONSORED CONTENT

Join us for in an informative and timely 340B webinar scheduled for March 13th at 11:30 AM CT! Ted Slafsky, CEO of 340B Report, and Kristin Fox-Smith from Visante will share insights on 340B policy and litigation updates, along with valuable strategies to enhance and streamline your 340B program. Registration is complimentary, but spots are limited, so secure your spot today!

Visante logo and tagline
Read More »

Idaho Becomes Nineteenth State to Introduce a 340B Contract Pharmacy Bill

Idaho is the nineteenth state to introduce legislation to bar drugmaker 340B contract pharmacy restrictions this session.
Idaho state lawmakers this week introduced a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Adds Drug to 340B Contract Pharmacy Restrictions

Takeda 340B
Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.
After implementing its first contract pharmacy restrictions in January, Japanese pharmaceutical giant Takeda recently subjected another drug to conditions on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Lacks Authority to Reverse 340B Child Site Registration Policy, Hospital Group Tells Court

U.S. District Court of the District of Columbia
A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.
A 340B hospital association this week asked a federal court to bar, without a full trial, federal regulators from reversing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen Extends Contract Pharmacy Restrictions to Grantees, Receives Early Pushback

Amgen wordmark on building facade
Drugmaker Amgen last week extended its existing 340B contract pharmacy restrictions to federal grantees.
Biopharmaceutical manufacturer Amgen recently expanded its conditions on 340B pricing at contract pharmacies to include grantees. The Thousand Oaks, California-based [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cybersecurity Disruption of Major Claims Processor Continues to Affect 340B Providers

Change Healthcare, a major pharmacy claims processor, disconnected pharmacy services following a recent cyberattack.
Change Healthcare’s systems are down for a seventh straight day after it disconnected pharmacy services following a Feb. 21 cyberattack. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Part 2 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

Holly Russo headshot

SPONSORED CONTENT

Part 2 of 2: Navigating staffing shortages, unpredictable demand, and complex industry requirements

While in-house pharmacies offer a wide array of benefits both for the community health center (CHC) and their patient populations, overseeing the myriad of administrative, operational, financial, and regulatory intricacies can prove difficult to manage. In Part 1 of this series, we covered two of the biggest challenges that CHCs face while operating in-house pharmacies: managing costs and ensuring favorable contracting.

In this follow-up, we explore the pressures facing CHCs due to pervasive staffing and retention challenges, fluctuating levels of patient demand, and nuanced regulatory complexities—and how CHCs can act to boost patient demand, improve clinical outcomes, and reinforce their financial health in 2024 and beyond. This is part two of a two-part series.

Challenge 3: Staffing shortages

Attracting and retaining pharmacy talent has

Read More »

New Hampshire Senate to Vote on 340B PBM Bill; Key Massachusetts State Committee Approves 340B Payment Bill

The New Hampshire state senate passed a bill that would prohibit certain 340B-specific PBM and health insurer policies.
The New Hampshire state senate will vote next month on a bill to bar certain 340B-specific pharmacy benefit manager (PBM) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

No Louisiana Move to ‘Investigate or Enforce’ Its 340B Contract Pharmacy Law, AG Tells Federal Judge

In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.
The Louisiana attorney general’s office last week told a federal district judge it had “not taken any action to investigate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report